105 related articles for article (PubMed ID: 20800933)
1. Synthesis, structural elucidation and DNA-dependant protein kinase and antiplatelet studies of 2-amino-[5, 6, 7, 8-mono and 7, 8-di-substituted]-1,3-benzoxazines.
Ihmaid S; Al-Rawi J; Bradley C
Eur J Med Chem; 2010 Nov; 45(11):4934-46. PubMed ID: 20800933
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
Pritchard KM; Al-Rawi J; Bradley C
Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines.
Ihmaid S; Al-Rawi J; Bradley C; Angove MJ; Robertson MN; Clark RL
Bioorg Med Chem; 2011 Jul; 19(13):3983-94. PubMed ID: 21664823
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 8-aryl-2-morpholino-7-O-substituted benzo[e][1,3]oxazin-4-ones against DNA-PK, PI3K, PDE3A enzymes and platelet aggregation.
Saifuzzaman M; Morrison R; Zheng Z; Orive S; Hamilton J; Thompson PE; Al-Rawi JMA
Bioorg Med Chem; 2017 Oct; 25(20):5531-5536. PubMed ID: 28838830
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 7-benzylamino-2H-1,4-benzoxazin-3(4H)-ones as anticonvulsant agents.
Piao ZT; Guan LP; Zhao LM; Piao HR; Quan ZS
Eur J Med Chem; 2008 Jun; 43(6):1216-21. PubMed ID: 17950496
[TBL] [Abstract][Full Text] [Related]
8. 1,4-Benzoxazine-3(4H)-ones as potent inhibitors of platelet aggregation: design, synthesis and structure-activity relations.
Liu C; Tan JL; Xiao SY; Liao JF; Zou GR; Ai XX; Chen JB; Xiang Y; Yang Q; Zuo H
Chem Pharm Bull (Tokyo); 2014; 62(9):915-20. PubMed ID: 25007750
[TBL] [Abstract][Full Text] [Related]
9. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.
Cano C; Barbeau OR; Bailey C; Cockcroft XL; Curtin NJ; Duggan H; Frigerio M; Golding BT; Hardcastle IR; Hummersone MG; Knights C; Menear KA; Newell DR; Richardson CJ; Smith GC; Spittle B; Griffin RJ
J Med Chem; 2010 Dec; 53(24):8498-507. PubMed ID: 21080722
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure elucidation, DNA-PK and PI3K and anti-cancer activity of 8- and 6-aryl-substituted-1-3-benzoxazines.
Morrison R; Al-Rawi JM; Jennings IG; Thompson PE; Angove MJ
Eur J Med Chem; 2016 Mar; 110():326-39. PubMed ID: 26854431
[TBL] [Abstract][Full Text] [Related]
11. Synthetic studies of cephalandole alkaloids and the revised structure of cephalandole A.
Mason JJ; Bergman J; Janosik T
J Nat Prod; 2008 Aug; 71(8):1447-50. PubMed ID: 18651770
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of linear and angular aryl-morpholino-naphth-oxazines, their DNA-PK, PI3K, PDE3A and antiplatelet activity.
Morrison R; Zheng Z; Jennings IG; Thompson PE; Al-Rawi JMA
Bioorg Med Chem Lett; 2016 Nov; 26(22):5534-5538. PubMed ID: 27765510
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and optimization of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one based inhibitors of human neutrophil elastase.
Shreder KR; Cajica J; Du L; Fraser A; Hu Y; Kohno Y; Lin EC; Liu SJ; Okerberg E; Pham L; Wu J; Kozarich JW
Bioorg Med Chem Lett; 2009 Aug; 19(16):4743-6. PubMed ID: 19577470
[TBL] [Abstract][Full Text] [Related]
14. 1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.
Roma G; Di Braccio M; Leoncini G; Aprile B
Farmaco; 1993 Sep; 48(9):1225-38. PubMed ID: 8259980
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimicrobial activity and QSARs of new benzoxazine-3-ones.
Alper-Hayta S; Aki-Sener E; Tekiner-Gulbas B; Yildiz I; Temiz-Arpaci O; Yalcin I; Altanlar N
Eur J Med Chem; 2006 Dec; 41(12):1398-404. PubMed ID: 16996656
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents.
Borate HB; Maujan SR; Sawargave SP; Chandavarkar MA; Vaiude SR; Joshi VA; Wakharkar RD; Iyer R; Kelkar RG; Chavan SP; Kunte SS
Bioorg Med Chem Lett; 2010 Jan; 20(2):722-5. PubMed ID: 19963383
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities.
Bayrak H; Demirbas A; Karaoglu SA; Demirbas N
Eur J Med Chem; 2009 Mar; 44(3):1057-66. PubMed ID: 18676062
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study.
Anderluh M; Cesar J; Stefanic P; Kikelj D; Janes D; Murn J; Nadrah K; Tominc M; Addicks E; Giannis A; Stegnar M; Dolenc MS
Eur J Med Chem; 2005 Jan; 40(1):25-49. PubMed ID: 15642407
[TBL] [Abstract][Full Text] [Related]
19. Copper(I)-catalyzed one-pot synthesis of 2H-1,4-benzoxazin-3-(4H)-ones from o-halophenols and 2-chloroacetamides.
Feng E; Huang H; Zhou Y; Ye D; Jiang H; Liu H
J Org Chem; 2009 Apr; 74(7):2846-9. PubMed ID: 19256470
[TBL] [Abstract][Full Text] [Related]
20. Novel potent and selective thrombin inhibitors based on a central 1,4-benzoxazin-3(4H)-one scaffold.
Ilas J; Tomasić T; Kikelj D
J Med Chem; 2008 May; 51(9):2863-7. PubMed ID: 18412326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
